Login / Signup

Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy.

Marco MiraniGiuseppe FavacchioFlaminia CarroneNazarena BetellaEmilia BiamonteEmanuela MorenghiGherardo MazziottiAndrea Gerardo Lania
Published in: Diabetes care (2020)
Plasma glucose levels at admission and antidiabetes drugs may influence the survival of COVID-19 patients affected by type 2 diabetes.
Keyphrases
  • sars cov
  • type diabetes
  • emergency department
  • coronavirus disease
  • healthcare
  • glycemic control
  • blood glucose
  • cardiovascular disease
  • respiratory syndrome coronavirus
  • adverse drug
  • insulin resistance
  • adipose tissue